Menarini Group to buy Stemline Therapeutics in deal valued at up to $677 mln
May 04, 2020 at 07:20 AM EDT
Privately held Italian drugmaker Menarini Group on Monday agreed to buy U.S. company Stemline Therapeutics Inc in a deal valued at up to $677 million.
